4 Results for "

AGA Inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "AGA Inhibitors" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-118528A
CAS No.: 2459963-17-6
Purity:  99.22%
Target:  

TGF-β Receptor

Research Areas:  

Endocrinology

TP0427736 hydrochloride is a potent inhibitor of ALK5 kinase activity with an IC50 of 2.72 nM and this effect is 300-fold higher than the inhibitory effect on ALK3 (IC50=836 nM). TP0427736 hydrochloride also inhibits Smad2/3 phosphorylation in A549 cells induced by TGF-β1 with an IC50 value of 8.68 nM. TP0427736 hydrochloride can be used for the research of androgenic alopecia (AGA) .
loading...
    loading...
Cat. No.: HY-161618
CAS No.: 2099014-23-8
Target:  

JAK EGFR PI3K IGF-1R GSK-3

MJ04 is a selective inhibitor for Janus Kinase 3 (JAK 3) with an IC50 of 2.03 nM. MJ04 inhibits T cell differentation and inhibits the proinfammatory cytokines in Lipopolysaccharides (HY-D1056)‑induced macrophages. MJ04 exhibits good pharmacokinetic characters in mice, promotes hair growth in DHT-induced androgenetic alopecia (AGA) in athymic mice model, without significant toxicity (LD50 >2 g/kg) .
loading...
    loading...
Cat. No.: HY-175719
Target:  

5 alpha Reductase

Research Areas:  

Endocrinology

SRD5A1-IN-2 is a inhibitor of steroid 5α-reductase type-1 (SRD5A1), with an IC50 of 8.5 μM. SRD5A1-IN-2 downregulates SRD5A1 protein expression in HaCaT cells. SRD5A1-IN-2 reduces dihydrotestosterone (DHT) production in HaCaT cells. SRD5A1-IN-2 can be used for the study of androgen-related conditions such as androgenetic alopecia (AGA) .
loading...
    loading...
Cat. No.: HY-P992113
CAS No.: 3061142-96-6
Synonyms: AGA2118
Target:  

Wnt β-catenin

Research Areas:  

Metabolic Disease

Evabosmig (AGA2118) is a humanized bispecific monoclonal antibody targeting sclerostin (SOST/sclerostin) and DKK1. SOST and DKK1 are two key secreted negative regulators of the intramedullary Wnt/β-catenin pathway. Evabosmig possesses activities to induce bone formation, inhibit bone resorption and increase bone mineral density. Evabosmig is applicable for research related to osteoporosis .
loading...
    loading...